Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $15.4900 (-6.12%) ($15.4900 - $16.4100) on Fri. Mar. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 31 | Latest Price | $15.4900(-6.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(54%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting HALO price | HALO will decline at least -1.35% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-5%) TLT(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | 0 () | Intraday Trend | -5.5% | | | |
|
Resistance Level | $16.49 | 5 Day Moving Average | $16.36(-5.32%) | 10 Day Moving Average | $16.18(-4.26%) | 20 Day Moving Average | $16.49(-6.06%) | To recent high | -11.9% | To recent low | 16.2% | Market Cap | $2.117b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |